Production (Stage)
Pacific Biosciences of California, Inc.
PACB
$1.14
$0.1414.00%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18,070.27% | 103.90% | 64.96% | -121.70% | 4.68% |
| Total Depreciation and Amortization | 3,304.69% | -31.99% | 12.67% | 18.94% | 2.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 122.22% | -418.53% | -85.21% | 601.81% | -22.78% |
| Change in Net Operating Assets | -128.53% | 148.45% | -172.84% | 75.03% | -227.49% |
| Cash from Operations | -43.74% | 32.58% | 16.22% | 28.30% | -31.48% |
| Capital Expenditure | 14.10% | -305.46% | 153.21% | 61.87% | -91.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.11% | 168.67% | -71.55% | 358.84% | 53.13% |
| Cash from Investing | -22.33% | 152.50% | -69.98% | 325.09% | 48.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 55.03% | 24.04% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | 636.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.90% | -6,282.27% | 634.21% | -102.32% | 108.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.87% | -4.75% | -196.27% | 121.71% | 49.81% |